Prosecution Insights
Last updated: April 19, 2026
Application No. 18/254,905

POLYMER ABLE TO FORM A SLIPPERY COATING FOR AN OPHTHALMIC INJECTOR

Non-Final OA §103
Filed
May 30, 2023
Examiner
LEONARD, MICHAEL L
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Polymerexpert SA
OA Round
1 (Non-Final)
64%
Grant Probability
Moderate
1-2
OA Rounds
3y 3m
To Grant
72%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allow Rate
839 granted / 1319 resolved
-1.4% vs TC avg
Moderate +8% lift
Without
With
+8.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
64 currently pending
Career history
1383
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
50.5%
+10.5% vs TC avg
§102
19.2%
-20.8% vs TC avg
§112
18.7%
-21.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1319 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 7 is rejected under 35 U.S.C. 103 as being unpatentable over CN-107286313 to Jing et al. As to claim 7, Jing discloses a method for preparing a polymer of the following formula: PNG media_image1.png 138 640 media_image1.png Greyscale PNG media_image2.png 258 502 media_image2.png Greyscale by reacting polyethylene glycol with a molecular weight of 600 or 1,000 (0081, 0093) and polycaprolactone diol with a molecular weight of 2,276 (0079-0081) with hexamethylene diisocyanate, and 1,4-butanediol in a ratio of PEG:PCL of 2:8-8:2 (0012-0021) to obtain a polyurethane with a molecular weight of 80,000-120,000 (0021). The content of PEG and PCL overlap the claimed range. It is well settled that where prior art describes components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations a prima facie case of obviousness is established. See MPEP 2144.05. In light of the cited patent case law, it would therefore have been obvious that in this particular instance to use more PEG that falls within the claimed range based on prior art presented that disclosed wherein the content of hydrophilic polyol (PEG) to biodegradable polyol (PCL) is selected to provide polyurethanes with a desired balance of properties relating to water absorption, degradation, porosity, and elasticity (0027). Claims 1-4, 6-7, 13, 20-23, and 26-29 are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Pub. No. 2016/0015865 to Dolatkhani et al. As to claims 1-4, 6-7, 13, 20-23, and 26-29, Dolatkhani discloses polymer compositions for application to ophthalmic injectors to provide slippery surfaces to the surface tip of the injectors (0012, 0019, 0034, 0074-0076) comprising hydrophilic and hydrophobic portions wherein the content of hydrophilic portion ranges from 60 to 99% by mass (0065) comprising the reaction of 400 grams of polyethylene glycol diol (M.W. of 6,000), 100 grams of polycaprolactone diol (M.W. of 1,250), and dicyclohexylmethane diisocyanate (Example 3). Dolatkhani discloses molar masses of the polymer of greater than 10,000 g/mol to 100,000 g/mol (0062). The polymer has a melting temperature range from 40 to 53°C (Example 3). The molar mass of the polyurethane overlaps the claimed range. At the time of filing it would have been obvious to maintain the molecular weight within the claimed range to limit their solubilization in the aqueous phase and to withstand the conditions of processing by injection moldings without chemical or structural degradation (0063). Allowable Subject Matter Claims 8-12, 17-19, and 24-25 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL L LEONARD whose telephone number is (571)270-7450. The examiner can normally be reached M - F 7:00-4:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL L LEONARD/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

May 30, 2023
Application Filed
Jan 08, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600811
CROSSLINKING AGENT COMPOSITION FOR WATER-COMPATIBLE RESIN, AND WATER-COMPATIBLE RESIN COMPOSITION
2y 5m to grant Granted Apr 14, 2026
Patent 12583819
POLYTHIOL COMPOSITION, OPTICAL POLYMERIZABLE COMPOSITION, AND OPTICAL PRODUCT
2y 5m to grant Granted Mar 24, 2026
Patent 12583993
RECYCLED POLYOL
2y 5m to grant Granted Mar 24, 2026
Patent 12570789
CURABLE COMPOUND, CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURABLE COMPOSITION
2y 5m to grant Granted Mar 10, 2026
Patent 12565561
HEAT-SHRINKABLE POLYESTER-BASED FILM, HEAT-SHRINKABLE LABEL, AND PACKAGING BODY
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
64%
Grant Probability
72%
With Interview (+8.0%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 1319 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month